JPMorgan Chase & Co’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.5M Sell
91,153
-9,621
-10% -$1.32M ﹤0.01% 2046
2025
Q1
$18.2M Sell
100,774
-51,061
-34% -$9.21M ﹤0.01% 1766
2024
Q4
$23.8M Buy
151,835
+23,934
+19% +$3.75M ﹤0.01% 1615
2024
Q3
$23.3M Sell
127,901
-35,923
-22% -$6.54M ﹤0.01% 1613
2024
Q2
$30.1M Sell
163,824
-11,302
-6% -$2.08M ﹤0.01% 1396
2024
Q1
$31.2M Sell
175,126
-38,393
-18% -$6.83M ﹤0.01% 1422
2023
Q4
$26.5M Sell
213,519
-7,974
-4% -$989K ﹤0.01% 1445
2023
Q3
$25.7M Sell
221,493
-18,290
-8% -$2.12M ﹤0.01% 1351
2023
Q2
$28.2M Buy
239,783
+1,374
+0.6% +$161K ﹤0.01% 1328
2023
Q1
$19.1M Buy
238,409
+472
+0.2% +$37.8K ﹤0.01% 1507
2022
Q4
$18.8M Sell
237,937
-4,756
-2% -$377K ﹤0.01% 1477
2022
Q3
$16.9M Sell
242,693
-15,874
-6% -$1.11M ﹤0.01% 1495
2022
Q2
$17M Buy
258,567
+706
+0.3% +$46.4K ﹤0.01% 1533
2022
Q1
$17.2M Buy
257,861
+58,228
+29% +$3.87M ﹤0.01% 1664
2021
Q4
$14M Sell
199,633
-24,786
-11% -$1.73M ﹤0.01% 1835
2021
Q3
$11.7M Sell
224,419
-186,462
-45% -$9.74M ﹤0.01% 1937
2021
Q2
$27.9M Buy
410,881
+26,603
+7% +$1.81M ﹤0.01% 1402
2021
Q1
$29.6M Buy
384,278
+144,966
+61% +$11.2M ﹤0.01% 1330
2020
Q4
$14.4M Buy
239,312
+153,490
+179% +$9.21M ﹤0.01% 1680
2020
Q3
$3.62M Buy
85,822
+18,223
+27% +$769K ﹤0.01% 2418
2020
Q2
$2.8M Buy
67,599
+20,954
+45% +$868K ﹤0.01% 2508
2020
Q1
$2.02M Buy
46,645
+26,892
+136% +$1.16M ﹤0.01% 2588
2019
Q4
$1.09M Buy
19,753
+16,312
+474% +$903K ﹤0.01% 3012
2019
Q3
$119K Sell
3,441
-16,065
-82% -$556K ﹤0.01% 3927
2019
Q2
$741K Buy
19,506
+12,891
+195% +$490K ﹤0.01% 3188
2019
Q1
$218K Buy
6,615
+5,402
+445% +$178K ﹤0.01% 3736
2018
Q4
$25K Sell
1,213
-34,920
-97% -$720K ﹤0.01% 4459
2018
Q3
$635K Buy
36,133
+14,755
+69% +$259K ﹤0.01% 3395
2018
Q2
$318K Buy
+21,378
New +$318K ﹤0.01% 3640